In 1988 the FDA approved the use of Gadolinium for use as a contrast agent in MRI’s. Contrast agents help in enhancing the clarity of MRI images. Gadolinium bonds with damaged or diseased tissues giving doctors a much clearer picture of organs that they would without. On June 8, 2006 the FDA issued a warning… Continue Reading